Market News & Trends
PROMETRIKA Partners With Comprehend to Enhance its Full-Service Clinical Trial Offering
PROMETRIKA, LLC and Comprehend Systems, Inc. recently announce a partnership that will provide innovative solutions to meet the evolving needs of biotech and pharmaceutical sponsors…
Atlas Nanotech Opens First Revenue Stream With Gem Labs Contract
The contract calls for Atlas to sell stabilized and functionalized silver nanoparticles to Gem Labs for use in the manufacture of one of Gem Labs proprietary products.
LabTwin Partners With Bonneville Labs & Lab Launch to Give Biotech Startups Access to World’s First Voice & AI-Powered Digital Lab Assistant
LabTwin GmbH, the world’s first voice and AI-powered digital lab assistant, recently announced partnerships with CA-based life science shared lab facilities Bonneville Labs and Lab Launch to……
Quotient Sciences to Recapitalize With Global Private Equity Firm
Quotient Sciences and global investment firm Permira recently announced that a company backed by the Permira Funds has signed a definitive agreement to acquire a majority stake in…….
Pfenex & Arcellx Announce Development, Evaluation & License Agreement
Pfenex Inc. and Arcellx, Inc. recently announced a Development, Evaluation, and License agreement under which Arcellx gains access to the proprietary Pfenex Expression Technology platform to advance……
Noramco & SPI Pharma Announce Availability of New Excipient Compatibility Study
Noramco and SPI Pharma recently announced they have completed work on an excipient compatibility study examining a range of options for the development of….
Catalent Extends Global Commercial Spray Drying Capabilities
Catalent, Inc. recently announced it has significantly expanded the capacity of its global spray drying operations through an agreement with….
Incyte & Zai Lab Announce Collaboration & License Agreement
Incyte and Zai Lab Ltd. recently announced that the companies have entered into a collaboration and license agreement for the development and commercialization of
Amicus Therapeutics & Catalent Biologics Enter Strategic Partnership
Amicus Therapeutics, Inc. has entered into a strategic manufacturing agreement with Paragon Gene Therapy, a unit of Catalent Biologics, for clinical manufacturing capabilities and capacity for….
Calithera Biosciences Initiates Phase 1/2 Trial
Calithera Biosciences, Inc. recently announced treatment of the first patient in a Phase 1/2 open-label clinical trial of the glutaminase inhibitor telaglenastat (CB-839) in combination…
Appili Therapeutics Signs $3-Million Grant to Develop Antibiotics That Target Superbugs
Appili Therapeutics Inc. recently announced the United States Department of Defense, (DOD) Congressionally Directed Medical Research Programs, Peer Reviewed Medical Research Program (PRMRP) has completed…
Amicus Therapeutics & Brammer Bio Enter Strategic Development & Manufacturing Collaboration
Amicus Therapeutics, Inc. has entered into a strategic manufacturing collaboration with Thermo Fisher Scientific. Thermo Fisher, a best-in-class contract development and manufacturing organization (CDMO) with…
Therapeutic Solutions International Obtains Exclusive License for Patented Clinical Stage Adult Stem Cell
Therapeutics Solutions International, Inc. recently announced signing of a license agreement providing exclusive rights to a patented adult stem cell for development of therapeutics in…
Y-mAbs Announces Recruitment Status for Pivotal Trials
Y-mAbs Therapeutics, Inc. recently announced the status of patient recruitment for the company’s two pivotal Phase 2 trials, one for omburtamab for the treatment of…
Verrica Pharmaceuticals Enrolls First Patient in Phase 2 Trial
Verrica Pharmaceuticals Inc. recently announced that the first patient has been enrolled in the company’s Phase 2 ‘CARE’ clinical trial evaluating the optimal dose regimen,…
Arcturus Therapeutics Receives Orphan Drug Designation
Arcturus Therapeutics Holdings Inc. recently announced the US FDA has granted Orphan Drug Designation for the company’s lead product candidate………
Athenex Announces Strategic Global Initiatives
Athenex, Inc. recently announced it has strategically expanded its presence in Europe and Latin America to grow its global……
Esperion & Oberland Capital Announce $200-Million Agreement
Esperion recently announced a $200 million capped, tiered, revenue-based funding agreement on net revenues of bempedoic acid and the bempedoic acid / ezetimibe combination tablet.…
Seelos Therapeutics Announces Acquisition of Exclusive Worldwide License of Gene Therapy Program
Seelos Therapeutics, Inc. recently announced the exclusive worldwide licensing of a gene therapy program targeting the regulation of the SNCA gene, which encodes alpha-synuclein expression, …
SunGen Pharma Announces Partnership With Athenex Pharmaceutical
SunGen Pharma recently announced to launch Bivalirudin for Injection in the near future through their joint venture Peterson Athenex with Athenex Pharmaceuticals. This tentatively approved…
